Ollin Biosciences

Ollin Biosciences

Ollin Biosciences

Clinical-stage biopharmaceutical company developing therapies for serious eye diseases.

Active
Rate

About

Ollin Biosciences, Inc. is a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.

Where Ollin Biosciences is heading

Updated Nov 16, 2026, from 7 sources

Ollin Biosciences is a clinical-stage company developing OLN324, a treatment for diabetic macular edema and wet age-related macular degeneration.ollin.bio Its 2026 record shows head-to-head data against Vabysmo, a $330 million Series B, presentations at two major retina conferences, and an acquisition announced in November 2026.ollin.bio

  1. Mar 2026

    Published final data from a randomized head-to-head study of OLN324 against faricimab (Vabysmo) in wet AMD and diabetic macular edema.ollin.bio

  2. Jun 2026

    Raised an oversubscribed $330 million Series B to advance global Phase 3 development of OLN324 in DME and wet AMD, with studies starting in the second half of 2026.ollin.bio

  3. Jul 2026

    Presented OLN324 data in diabetic macular edema and wet AMD at the American Society of Retina Specialists 44th Annual Scientific Meeting.ollin.bio

  4. Sep 2026

    Presented at EURETINA 2026.ollin.bio

  5. Nov 2026

    Announced acquisition of the company and its next-generation medicines for vision-threatening eye diseases.ollin.bio

What it points to: Its head-to-head data against Vabysmo, an oversubscribed $330 million Phase 3 financing, and acquisition announcement point to OLN324 having built enough clinical momentum to attract a strategic buyer.ollin.bio

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Ollin Biosciences?

People comparing tools land here. Get listed beside these.

All funding rounds

Key facts

Website
ollin.bio
Business model
B2B

Tech stack

Detected on ollin.bio, last scanned 16 Nov 2026.

SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Microsoft 365

Benchmarking

See how your site ranks against 16,849 startups

Ollin Biosciences sits in the 17th percentile for Domain Rating. Check where yours lands, free.

Check your Domain Rating

Ollin Biosciences has a Domain Rating of 10, the 17th percentile of 16,849 startups we track.

Scores

Measured, not editorial

10

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Bottom 25%

Check yours
42

Measured by StartupHub.aiEffective DR

Our own read on real cross-surface visibility rather than raw backlink authority. A site can carry a high Domain Rating and still be invisible where people actually look, which is what this measures.

Bottom 25%

Check yours
51

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Top 25%

Scan yours
74

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Above median

PageSpeed

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Ollin Biosciences scores 51. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Ollin Biosciences changes

Used Ollin Biosciences? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Are there companies like Ollin Biosciences?

Yes. We list 7 companies like Ollin Biosciences, including Apellis Pharmaceuticals, Infinimmune and LifeMine Therapeutics Inc..

SEC filings, insider activity, nonprofit links and pay benchmarks for Ollin Biosciences:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Ollin Biosciences and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini